RegeneRx Biopharmaceuticals, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Public
- Established
- 2002-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://www.regenerx.com
A Study of the Safety and Efficacy of Injectable Thymosin Beta 4 for Treating Acute Myocardial Infarction
Phase 2
Withdrawn
- Conditions
- ST Elevation Myocardial InfarctionAcute Myocardial InfarctionSTEMI
- First Posted Date
- 2011-03-09
- Last Posted Date
- 2021-09-22
- Lead Sponsor
- RegeneRx Biopharmaceuticals, Inc.
- Registration Number
- NCT01311518
Study of Thymosin Beta 4 in Patients With Venous Stasis Ulcers
- First Posted Date
- 2009-01-29
- Last Posted Date
- 2010-03-30
- Lead Sponsor
- RegeneRx Biopharmaceuticals, Inc.
- Target Recruit Count
- 72
- Registration Number
- NCT00832091
- Locations
- 🇮🇹
Università degli Studi di Napoli - Federico II, Naples, Italy
🇮🇹Istituto Dermopatico dell'Immacolata (IDI), Rome, Italy
🇵🇱Klinika Chirurgii Naczyń i Angiologii, Lublin, Poland
A Phase 1 Safety Study of the Intravenous Administration of Thymosin Beta in Healthy Volunteers
Phase 1
Withdrawn
- Conditions
- Myocardial IschemiaMyocardial Infarction
- Interventions
- Other: PlaceboDrug: thymosin beta 4
- First Posted Date
- 2008-08-29
- Last Posted Date
- 2017-04-17
- Lead Sponsor
- RegeneRx Biopharmaceuticals, Inc.
- Registration Number
- NCT00743769
- Locations
- 🇺🇸
Healthcare Discoveries LLC, San Antonio, Texas, United States
Study of Thymosin Beta 4 in Patients With Pressure Ulcers
- First Posted Date
- 2006-09-28
- Last Posted Date
- 2010-02-01
- Lead Sponsor
- RegeneRx Biopharmaceuticals, Inc.
- Target Recruit Count
- 72
- Registration Number
- NCT00382174
- Locations
- 🇺🇸
Impact Clinical Trials, Beverly Hills, California, United States
🇺🇸Hines VAMC, Hines, Illinois, United States
🇺🇸Institute for Advanced Wound Care, Montgomery, Alabama, United States
A Phase 2 Study on Effect of Thymosin Beta 4 on Wound Healing in Patients With Epidermolysis Bullosa
- First Posted Date
- 2006-04-06
- Last Posted Date
- 2014-05-12
- Lead Sponsor
- RegeneRx Biopharmaceuticals, Inc.
- Target Recruit Count
- 30
- Registration Number
- NCT00311766
© Copyright 2025. All Rights Reserved by MedPath